Advertisement

GeroScience

pp 1–13 | Cite as

Polygenic risk score for disability and insights into disability-related molecular mechanisms

  • Alexander M. KulminskiEmail author
  • Chansuk Kang
  • Stanislav A. Kolpakov
  • Yury Loika
  • Alireza Nazarian
  • Anatoliy I. Yashin
  • Eric Stallard
  • Irina Culminskaya
Original Article

Abstract

Late life disability is a highly devastating condition affecting 20% or more of persons aged 65 years and older in the USA; it is an important determinant of acute medical and long-term care costs which represent a growing burden on national economies. Disability is a multifactorial trait that contributes substantially to decline of health/wellbeing. Accordingly, gaining insights into the genetics of disability could help in identifying molecular mechanisms of this devastating condition and age-related processes contributing to a large fraction of specific geriatric conditions, concordantly with geroscience. We performed a genome-wide association study of disability in a sample of 24,068 subjects from five studies with 12,550 disabled individuals. We identified 30 promising disability-associated polymorphisms in 19 loci at p < 10−4; four of them attained suggestive significance, p < 10−5. In contrast, polygenic risk scores aggregating effects of minor alleles of independent SNPs that were adversely or beneficially associated with disability showed highly significant associations in meta-analysis, p = 3.13 × 10−45 and p = 5.60 × 10−23, respectively, and were replicated in each study. The analysis of genetic pathways, related diseases, and biological functions supported the connections of genes for the identified SNPs with disabling and age-related conditions primarily through oxidative/nitrosative stress, inflammatory response, and ciliary signaling. We identified musculoskeletal system development, maintenance, and regeneration as important components of gene functions. The beneficial and adverse gene sets may be differently implicated in the development of musculoskeletal-related disability with the beneficial set characterized, e.g., by regulation of chondrocyte proliferation and bone formation, and the adverse set by inflammation and bone loss.

Keywords

Disability Polygenic risk score Genetic architecture Biological function 

Notes

Author contributions

A.M.K. conceived and designed the experiment and wrote the paper; C.K., S.A.K., and Y.L. performed statistical analyses; C.K., A.I.Y., and E.S. contributed to drafting of the paper. C.K., A.N., and I.C. prepared data. I.C. performed biological analysis

Funding information

This research was supported by the National Institute on Aging (grant numbers P01 AG043352, R01 AG047310, and R01 AG061853). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This manuscript was prepared using limited access datasets obtained though the dbGaP (accession numbers phs000315.v7.p3, phs000675.v3.p3, phs000287.v3.p1, phs000007.v29.p10, and phs000428.v1.p1) and the University of Michigan. See also Supporting Acknowledgment Text in Online Resource 1.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

11357_2019_125_MOESM1_ESM.docx (21 kb)
Online Resource 1 (DOCX 21.3 kb)
11357_2019_125_MOESM2_ESM.docx (20 kb)
Online Resource 2 (DOCX 20.1 kb)
11357_2019_125_MOESM3_ESM.docx (21 kb)
Online Resource 3 (DOCX 20.1 kb)
11357_2019_125_MOESM4_ESM.xlsx (20 kb)
Online Resource 4 (XLSX 20 kb)
11357_2019_125_MOESM5_ESM.xlsx (16 kb)
Online Resource 5 (XLSX 15 kb)

References

  1. Adams PF, Hendershot GE, Marano MA (1999) Current estimates from the National Health Interview Survey, 1996. Vital and health statistics. Series 10, Data from the National Health Survey ; no. 200. U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, Hyattsville, Md.Google Scholar
  2. Akesson K, Tenne M, Gerdhem P, Luthman H, McGuigan FE (2015) Variation in the PTH2R gene is associated with age-related degenerative changes in the lumbar spine. J Bone Miner Metab 33:9–15.  https://doi.org/10.1007/s00774-013-0550-x CrossRefPubMedGoogle Scholar
  3. Baig MS et al (2015) NOS1-derived nitric oxide promotes NF-kappaB transcriptional activity through inhibition of suppressor of cytokine signaling-1. J Exp Med 212:1725–1738.  https://doi.org/10.1084/jem.20140654 CrossRefPubMedPubMedCentralGoogle Scholar
  4. Baker K, Beales PL (2009) Making sense of cilia in disease: the human ciliopathies. Am J Med Genet C: Semin Med Genet 151C:281–295.  https://doi.org/10.1002/ajmg.c.30231 CrossRefGoogle Scholar
  5. Bogdan C (2001) Nitric oxide and the immune response. Nat Immunol 2:907–916.  https://doi.org/10.1038/ni1001-907 CrossRefPubMedGoogle Scholar
  6. Brodie A, Azaria JR, Ofran Y (2016) How far from the SNP may the causative genes be? Nucleic Acids Res 44:6046–6054.  https://doi.org/10.1093/nar/gkw500 CrossRefPubMedPubMedCentralGoogle Scholar
  7. Cupples LA, Heard-Costa N, Lee M, Atwood LD (2009) Genetics analysis workshop 16 problem 2: the Framingham Heart Study data. BMC Proc 3 Suppl 7:S3Google Scholar
  8. Dai Z, Chung SK, Miao D, Lau KS, Chan AW, Kung AW (2011) Sodium/myo-inositol cotransporter 1 and myo-inositol are essential for osteogenesis and bone formation. J Bone Miner Res 26:582–590.  https://doi.org/10.1002/jbmr.240 CrossRefPubMedGoogle Scholar
  9. Das S et al (2016) Next-generation genotype imputation service and methods. Nat Genet 48:1284–1287.  https://doi.org/10.1038/ng.3656 CrossRefPubMedPubMedCentralGoogle Scholar
  10. Davies JMS et al (2017) The Oxygen Paradox, the French Paradox, and age-related diseases. GeroScience 39:499–550.  https://doi.org/10.1007/s11357-017-0002-y CrossRefPubMedPubMedCentralGoogle Scholar
  11. Delaneau O, Marchini J, Zagury JF (2011) A linear complexity phasing method for thousands of genomes. Nat Methods 9:179–181.  https://doi.org/10.1038/nmeth.1785 CrossRefPubMedGoogle Scholar
  12. Finch CE (2018) The biology of human longevity: Inflammation, nutrition, and aging in the evolution of lifespans. Elsevier,Google Scholar
  13. Findlay DM, Atkins GJ (2014) Osteoblast-chondrocyte interactions in osteoarthritis. Curr Osteoporos Rep 12:127–134.  https://doi.org/10.1007/s11914-014-0192-5 CrossRefPubMedPubMedCentralGoogle Scholar
  14. Franceschi C, Garagnani P (2016) Suggestions from geroscience for the genetics of age-related diseases. PLoS Genet 12:e1006399.  https://doi.org/10.1371/journal.pgen.1006399 CrossRefPubMedPubMedCentralGoogle Scholar
  15. Franco OH, Karnik K, Osborne G, Ordovas JM, Catt M, van der Ouderaa F (2009) Changing course in ageing research: the healthy ageing phenotype. Maturitas 63:13–19.  https://doi.org/10.1016/j.maturitas.2009.02.006 CrossRefPubMedGoogle Scholar
  16. Fried LP, Guralnik JM (1997) Disability in older adults: evidence regarding significance, etiology, and risk. J Am Geriatr Soc 45:92–100CrossRefGoogle Scholar
  17. Fried LP et al (1991) The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1:263–276CrossRefGoogle Scholar
  18. Fried LP et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156CrossRefGoogle Scholar
  19. Fries JF (1980) Aging, natural death, and the compression of morbidity. N Engl J Med 303:130–135CrossRefGoogle Scholar
  20. Garatachea N, Lucia A (2013) Genes and the ageing muscle: a review on genetic association studies. Age (Dordr) 35:207–233.  https://doi.org/10.1007/s11357-011-9327-0 CrossRefGoogle Scholar
  21. Goldring MB (2012) Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis. Ther Adv Musculoskelet Dis 4:269–285.  https://doi.org/10.1177/1759720X12448454 CrossRefPubMedPubMedCentralGoogle Scholar
  22. Guarente L (2011) Franklin H. Epstein lecture: sirtuins, aging, and medicine. N Engl J Med 364:2235–2244.  https://doi.org/10.1056/NEJMra1100831 CrossRefPubMedGoogle Scholar
  23. Guralnik JM, LaCroix AZ, Abbott RD, Berkman LF, Satterfield S, Evans DA, Wallace RB (1993) Maintaining mobility in late life. I. Demographic characteristics and chronic conditions. Am J Epidemiol 137:845–857CrossRefGoogle Scholar
  24. Harris JL, Yeh HW, Swerdlow RH, Choi IY, Lee P, Brooks WM (2014) High-field proton magnetic resonance spectroscopy reveals metabolic effects of normal brain aging. Neurobiol Aging 35:1686–1694.  https://doi.org/10.1016/j.neurobiolaging.2014.01.018 CrossRefPubMedPubMedCentralGoogle Scholar
  25. Haycraft CJ, Serra R (2008) Cilia involvement in patterning and maintenance of the skeleton. Curr Top Dev Biol 85:303–332.  https://doi.org/10.1016/S0070-2153(08)00811-9 CrossRefPubMedPubMedCentralGoogle Scholar
  26. Hayes JD, McLellan LI (1999) Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 31:273–300CrossRefGoogle Scholar
  27. Heckerman D, Traynor BJ, Picca A, Calvani R, Marzetti E, Hernandez D, Nalls M, Arepali S, Ferrucci L, Landi F (2017) Genetic variants associated with physical performance and anthropometry in old age: a genome-wide association study in the ilSIRENTE cohort. Sci Rep 7:15879.  https://doi.org/10.1038/s41598-017-13475-0 CrossRefPubMedPubMedCentralGoogle Scholar
  28. Hinrichs AS et al (2006) The UCSC Genome Browser Database: update 2006. Nucleic Acids Res 34:D590–D598.  https://doi.org/10.1093/nar/gkj144 CrossRefPubMedGoogle Scholar
  29. Jitapunkul S, Kunanusont C, Phoolcharoen W, Suriyawongpaisal P, Ebrahim S (2003) Disability-free life expectancy of elderly people in a population undergoing demographic and epidemiologic transition. Age Ageing 32:401–405CrossRefGoogle Scholar
  30. Juster FT, Suzman R (1995) An overview of the health and retirement study. J Hum Resour 30:S7–S56CrossRefGoogle Scholar
  31. Kaeberlein M, Rabinovitch PS, Martin GM (2015) Healthy aging: the ultimate preventative medicine. Science 350:1191–1193.  https://doi.org/10.1126/science.aad3267 CrossRefPubMedPubMedCentralGoogle Scholar
  32. Kang EH, Lee YJ, Kim TK, Chang CB, Chung JH, Shin K, Lee EY, Lee EB, Song YW (2010) Adiponectin is a potential catabolic mediator in osteoarthritis cartilage. Arthritis Res Ther 12:R231.  https://doi.org/10.1186/ar3218 CrossRefPubMedPubMedCentralGoogle Scholar
  33. Katz S, Akpom CA (1976) 12. Index of ADL. Med Care 14:116–118CrossRefGoogle Scholar
  34. Khanshour AM et al (2018) Genome-wide meta-analysis and replication studies in multiple ethnicities identify novel adolescent idiopathic scoliosis susceptibility loci. Hum Mol Genet 27:3986–3998.  https://doi.org/10.1093/hmg/ddy306 CrossRefPubMedGoogle Scholar
  35. Kulminski A, Yashin A, Ukraintseva S, Akushevich I, Arbeev K, Land K, Manton K (2006) Accumulation of health disorders as a systemic measure of aging: findings from the NLTCS data. Mech Ageing Dev 127:840–848CrossRefGoogle Scholar
  36. Kulminski AM et al (2016) Pleiotropic associations of allelic variants in a 2q22 region with risks of major human diseases and mortality. PLoS Genet 12:e1006314.  https://doi.org/10.1371/journal.pgen.1006314 CrossRefPubMedPubMedCentralGoogle Scholar
  37. Kulminski AM, Loika Y, Huang J, Arbeev KG, Bagley O, Ukraintseva S, Yashin AI, Culminskaya I (2019) Pleiotropic meta-analysis of age-related phenotypes addressing evolutionary uncertainty in their molecular mechanisms. Front Genet 10:433.  https://doi.org/10.3389/fgene.2019.00433 CrossRefPubMedPubMedCentralGoogle Scholar
  38. Lewis R, Gomez Alvarez CB, Rayman M, Lanham-New S, Woolf A, Mobasheri A (2019) Strategies for optimising musculoskeletal health in the 21(st) century. BMC Musculoskelet Disord 20:164.  https://doi.org/10.1186/s12891-019-2510-7 CrossRefPubMedPubMedCentralGoogle Scholar
  39. Liguori I et al (2018) Oxidative stress, aging, and diseases. Clin Interv Aging 13:757–772.  https://doi.org/10.2147/CIA.S158513 CrossRefPubMedPubMedCentralGoogle Scholar
  40. Manichaikul A et al (2012) Analysis of family- and population-based samples in cohort genome-wide association studies. Hum Genet 131:275–287.  https://doi.org/10.1007/s00439-011-1071-0 CrossRefPubMedGoogle Scholar
  41. Manton KG (1982) Changing concepts of morbidity and mortality in the elderly population. Milbank Mem Fund Q Health Soc 60:183–244CrossRefGoogle Scholar
  42. Manton KG, Gu X, Lamb VL (2006) Change in chronic disability from 1982 to 2004/2005 as measured by long-term changes in function and health in the U.S. elderly population. Proc Natl Acad Sci U S A 103:18374–18379.  https://doi.org/10.1073/pnas.0608483103 CrossRefPubMedPubMedCentralGoogle Scholar
  43. Martin GM (2007) Modalities of gene action predicted by the classical evolutionary biological theory of aging. Ann N Y Acad Sci 1100:14–20.  https://doi.org/10.1196/annals.1395.002 CrossRefPubMedGoogle Scholar
  44. Martin GM, Austad SN, Johnson TE (1996) Genetic analysis of ageing: role of oxidative damage and environmental stresses. Nat Genet 13:25–34.  https://doi.org/10.1038/ng0596-25 CrossRefPubMedGoogle Scholar
  45. Meulenbelt I, Min JL, van Duijn CM, Kloppenburg M, Breedveld FC, Slagboom PE (2006) Strong linkage on 2q33.3 to familial early-onset generalized osteoarthritis and a consideration of two positional candidate genes. Eur J Hum Genet 14:1280–1287.  https://doi.org/10.1038/sj.ejhg.5201704 CrossRefPubMedGoogle Scholar
  46. Nishioka K et al (2008) Trps1 deficiency enlarges the proliferative zone of growth plate cartilage by upregulation of Pthrp. Bone 43:64–71.  https://doi.org/10.1016/j.bone.2008.03.009 CrossRefPubMedGoogle Scholar
  47. Ohyama Y et al (2012) Modulation of matrix mineralization by Vwc2-like protein and its novel splicing isoforms. Biochem Biophys Res Commun 418:12–16.  https://doi.org/10.1016/j.bbrc.2011.12.075 CrossRefPubMedGoogle Scholar
  48. Okoro CA, Hollis ND, Cyrus AC, Griffin-Blake S (2018) Prevalence of disabilities and health care access by disability status and type among adults - United States, 2016. MMWR 67:882–887.  https://doi.org/10.15585/mmwr.mm6732a3 CrossRefPubMedGoogle Scholar
  49. Olshansky SJ, Perry D, Miller RA, Butler RN (2007) Pursuing the longevity dividend: scientific goals for an aging world. Ann N Y Acad Sci 1114:11–13.  https://doi.org/10.1196/annals.1396.050 CrossRefPubMedGoogle Scholar
  50. Panda D, Goltzman D, Juppner H, Karaplis AC (2009) TIP39/parathyroid hormone type 2 receptor signaling is a potent inhibitor of chondrocyte proliferation and differentiation. Am J Physiol Endocrinol Metab 297:E1125–E1136.  https://doi.org/10.1152/ajpendo.00254.2009 CrossRefPubMedPubMedCentralGoogle Scholar
  51. Pham-Huy LA, He H, Pham-Huy C (2008) Free radicals, antioxidants in disease and health. Int J Biomed Sci 4:89–96PubMedPubMedCentralGoogle Scholar
  52. Pickrell JK, Berisa T, Liu JZ, Segurel L, Tung JY, Hinds DA (2016) Detection and interpretation of shared genetic influences on 42 human traits. Nat Genet 48:709–717.  https://doi.org/10.1038/ng.3570 CrossRefPubMedPubMedCentralGoogle Scholar
  53. Piscopo DM, Johansen EB, Derynck R (2009) Identification of the GATA factor TRPS1 as a repressor of the osteocalcin promoter. J Biol Chem 284:31690–31703.  https://doi.org/10.1074/jbc.M109.052316 CrossRefPubMedPubMedCentralGoogle Scholar
  54. Pope AM, Tarlov AR (1991) Disability in America : toward a national agenda for prevention. National Academy Press, Washington, D.C.Google Scholar
  55. Purcell S et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575.  https://doi.org/10.1086/519795 CrossRefPubMedPubMedCentralGoogle Scholar
  56. Qu XW, Wang H, De Plaen IG, Rozenfeld RA, Hsueh W (2001) Neuronal nitric oxide synthase (NOS) regulates the expression of inducible NOS in rat small intestine via modulation of nuclear factor kappa B. FASEB J 15:439–446.  https://doi.org/10.1096/fj.99-0343com CrossRefPubMedGoogle Scholar
  57. Rahmati M, Nalesso G, Mobasheri A, Mozafari M (2017) Aging and osteoarthritis: central role of the extracellular matrix. Ageing Res Rev 40:20–30.  https://doi.org/10.1016/j.arr.2017.07.004 CrossRefPubMedGoogle Scholar
  58. Robine J-M (2003) Determining health expectancies. Wiley, ChichesterGoogle Scholar
  59. Rockwood K, Mitnitski A (2011) Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med 27:17–26.  https://doi.org/10.1016/j.cger.2010.08.008 CrossRefPubMedGoogle Scholar
  60. Sabatier L, Miosge N, Hubmacher D, Lin G, Davis EC, Reinhardt DP (2011) Fibrillin-3 expression in human development. Matrix Biol 30:43–52.  https://doi.org/10.1016/j.matbio.2010.10.003 CrossRefPubMedGoogle Scholar
  61. Sierra F, Hadley E, Suzman R, Hodes R (2008) Prospects for life span extension. Annu Rev Med.  https://doi.org/10.1146/annurev.med.60.061607.220533 CrossRefGoogle Scholar
  62. Stallard E (2016) Compression of morbidity and mortality: new perspectives. N Am Actuar J 20:341–354.  https://doi.org/10.1080/10920277.2016.1227269 CrossRefPubMedPubMedCentralGoogle Scholar
  63. Stallard E (2019) Interactions of LTC morbidity and mortality. In: Dupourqué E, Planchet F, Sator N (eds) Actuarial Aspects of Long Term Care. Springer, Cham, pp 3–16CrossRefGoogle Scholar
  64. Stuck AE, Walthert JM, Nikolaus T, Bula CJ, Hohmann C, Beck JC (1999) Risk factors for functional status decline in community-living elderly people: a systematic literature review. Soc Sci Med (1982) 48:445–469CrossRefGoogle Scholar
  65. Sun MM, Beier F (2014) Chondrocyte hypertrophy in skeletal development, growth, and disease. Birth Defects Res C Embryo Today 102:74–82.  https://doi.org/10.1002/bdrc.21062 CrossRefPubMedGoogle Scholar
  66. Sun J et al (2017) Glutaredoxin 1 (GRX1) inhibits oxidative stress and apoptosis of chondrocytes by regulating CREB/HO-1 in osteoarthritis. Mol Immunol 90:211–218.  https://doi.org/10.1016/j.molimm.2017.08.006 CrossRefPubMedGoogle Scholar
  67. The Women’s Health Initiative Study Group (1998) Design of the Women’s Health Initiative clinical trial and observational study. Control Clin Trials 19:61–109CrossRefGoogle Scholar
  68. Theis KA, Steinweg A, Helmick CG, Courtney-Long E, Bolen JA, Lee R (2019) Which one? What kind? How many? Types, causes, and prevalence of disability among U.S. adults. Disabil Health J \:411-421. doi: https://doi.org/10.1016/j.dhjo.2019.03.001 CrossRefPubMedGoogle Scholar
  69. Trupin L, Rice DP, Max W (1995) Medical expenditures for people with disabilities in the United States, 1987. U.S. Dept. of Education, Office of Special Education and Rehabilitative Services, National Institute on Disability and Rehabilitation Research : Office of Educational Research and Improvement, Educational Resources Information Center,, [Washington, DC]Google Scholar
  70. Uldry M, Ibberson M, Horisberger JD, Chatton JY, Riederer BM, Thorens B (2001) Identification of a mammalian H(+)-myo-inositol symporter expressed predominantly in the brain. EMBO J 20:4467–4477.  https://doi.org/10.1093/emboj/20.16.4467 CrossRefPubMedPubMedCentralGoogle Scholar
  71. Veland IR, Awan A, Pedersen LB, Yoder BK, Christensen ST (2009) Primary cilia and signaling pathways in mammalian development, health and disease. Nephron Physiol 111:39–53.  https://doi.org/10.1159/000208212 CrossRefGoogle Scholar
  72. Visscher PM, Yang J (2016) A plethora of pleiotropy across complex traits. Nat Genet 48:707–708.  https://doi.org/10.1038/ng.3604 CrossRefPubMedGoogle Scholar
  73. Wheway G, Nazlamova L, Hancock JT (2018) Signaling through the primary cilium. Front Cell Dev Biol 6:8.  https://doi.org/10.3389/fcell.2018.00008 CrossRefPubMedPubMedCentralGoogle Scholar
  74. Willer CJ, Li Y, Abecasis GR (2010) METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26:2190–2191.  https://doi.org/10.1093/bioinformatics/btq340 CrossRefPubMedPubMedCentralGoogle Scholar
  75. Wink DA, Hines HB, Cheng RY, Switzer CH, Flores-Santana W, Vitek MP, Ridnour LA, Colton CA (2011) Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol 89:873–891.  https://doi.org/10.1189/jlb.1010550 CrossRefPubMedPubMedCentralGoogle Scholar
  76. Wuelling M, Kaiser FJ, Buelens LA, Braunholz D, Shivdasani RA, Depping R, Vortkamp A (2009) Trps1, a regulator of chondrocyte proliferation and differentiation, interacts with the activator form of Gli3. Dev Biol 328:40–53.  https://doi.org/10.1016/j.ydbio.2009.01.012 CrossRefPubMedGoogle Scholar
  77. Wuelling M, Pasdziernik M, Moll CN, Thiesen AM, Schneider S, Johannes C, Vortkamp A (2013) The multi zinc-finger protein Trps1 acts as a regulator of histone deacetylation during mitosis. Cell Cycle 12:2219–2232.  https://doi.org/10.4161/cc.25267 CrossRefPubMedPubMedCentralGoogle Scholar
  78. Xiong Y, Uys JD, Tew KD, Townsend DM (2011) S-glutathionylation: from molecular mechanisms to health outcomes. Antioxid Redox Signal 15:233–270.  https://doi.org/10.1089/ars.2010.3540 CrossRefPubMedPubMedCentralGoogle Scholar
  79. Yelin E, Weinstein S, King T (2016) The burden of musculoskeletal diseases in the United States. Semin Arthritis Rheum 46:259–260.  https://doi.org/10.1016/j.semarthrit.2016.07.013 CrossRefPubMedGoogle Scholar
  80. Zhavoronkov A, Moskalev A (2016) Editorial: should we treat aging as a disease? Academic, Pharmaceutical, Healthcare Policy, and Pension Fund Perspectives. Front Genet 7.  https://doi.org/10.3389/fgene.2016.00017

Copyright information

© American Aging Association 2019

Authors and Affiliations

  1. 1.Biodemography of Aging Research Unit, Social Science Research InstituteDuke UniversityDurhamUSA

Personalised recommendations